HOME >> BIOLOGY >> NEWS
Hold The Salt: Gene May Explain African Americans' Extra Sensitivity To Salt, Leading To High Blood Pressure

ORLANDO, Fla., March 24 -- Having a particular gene may make African Americans much more sensitive to salt, thereby increasing their risk of developing high blood pressure, according to a new report presented here today at the American Heart Association's epidemiology and prevention meeting.

Researchers say they have found that one variant of the angiotensin converting enzyme (ACE) gene can greatly influence an African American's susceptibility to salt, which is called salt-sensitivity. As little as one extra gram of salt, the amount in half a teaspoon of table salt or the 1,000 milligrams in one serving of some processed foods could raise blood pressure as much as five millimeters of mercury (mm Hg) in people who have the gene variant.

"This is a new finding -- no one has reported this association in African Americans," says the study's lead author, John M. Flack, M.D., professor and associate chairman, department of internal medicine, and director of the cardiovascular epidemiology and clinical applications program at Wayne State University in Detroit. African Americans are at greater risk of developing high blood pressure than the general population.

The body produces angiotensin to restrict blood vessels and help regulate blood pressure. The ACE gene controls the amount of angiotensin released into the body. If the ACE gene is flawed, it can cause the blood vessels to constrict too much, raising the pressure of blood flow on blood vessel walls and, consequently, increasing the risk of high blood pressure.

The researchers examined the influence of the ACE gene variant on blood pressure response to sodium intake in 81 African-American men and women who had normal blood pressure readings (less than 140/90 mm Hg). They found that the systolic blood pressure -- the upper number on a blood pressure reading -- rose sharply in those who consumed sodium and had the ACE gene variant when compared to those who did not have the variant.

The asso
'"/>

Contact: Carole Bullock
caroleb@heart.org
214-706-1279
American Heart Association
24-Mar-1999


Page: 1 2 3

Related biology news :

1. Explaining the persistence of Hepatitis C
2. Explaining how ozone "chokes up" plants
3. UCSF Lab Makes Observation That Could Explain Ability Of Modified Cold Virus To Kill Cancer Cells
4. A Mothers Love? New UD Theory Explains Why Good Insect Moms Risk Death To Save Their Only Children
5. Deaths of Zoo Elephants Explained -- New Virus Identified
6. UCSF/Gladstone Finding May Explain HIVS Ability To Infect Cells Lacking The Key Target Of HIV: The CD4 Receptor
7. UNC-CH Ligament-Tendon Structure Discovery May Lead To Better Treatment, Scientists Explain
8. Scientists Closer To Locating Gene That May Explain Cholesterol Absorption
9. University Of Texas Southwestern Researchers Find Genetic Switch That Explains Effect Of Exercise On Muscles
10. Duke Study Helps Explain How Cells Divvy Up Genes During Reproduction
11. CAK Activation Of Plant Cell Cycle: Scientists Find Another Piece In The Jigsaw Puzzle To Help Explain Why Plants Do Not Develop Cancer Spontaneously

Post Your Comments:
(Date:5/17/2013)... of all ages will celebrate the science and ... our daily lives during the inaugural Atlanta Science ... educators from local museums, corporations, K-12 schools and ... different events for children and adults at venues ... . , The annual Atlanta Science Festival ...
(Date:5/17/2013)... (Intelligent Cargo in Efficient and Sustainable Global Logistics Operations) ... improvement in the efficiency of intermodal loading systems and ... It comprises 29 European organisations with experience in the ... a budget totalling 17,000,000 and a duration of three ... specify and develop the semantic components and ontologies shared ...
(Date:5/17/2013)... An international team of scientists using a new ... inside a living frog embryo in greater detail than ... advance biological research and the search for new treatments ... Karlsruher Institut fr Technologie in Germany, in collaboration with ... Energy,s Argonne National Laboratory, released the most precise depiction ...
Breaking Biology News(10 mins):First Atlanta Science Festival set for 2014 2New logistics services that will cut energy consumption and CO2 emissions 2New X-ray method shows how frog embryos could help thwart disease 2
(Date:5/20/2013)... Ras Al Khaimah, UAE (PRWEB) May 21, 2013 ... and private equity consultancy specializing in “game-changing” life science ... appointment of Ms. Dalia Dergham to its International Project ... certain to bring even greater multi-cultural depth to Grace ... more projects around the globe. , Ms. Dergham holds ...
(Date:5/20/2013)... , May 20, 2013 Today, at the ... Francisco , James McGough , ... at the Semel Institute for Neuroscience and Human Behavior ... Medicine at the University of California Los Angeles (UCLA), ... and Adolescent Psychopharmacology and ADHD at UCLA, presented the ...
(Date:5/20/2013)... SEATTLE , May 20, 2013 Pacific Biomarkers ... laboratory solutions for developers of biosimilars at the ... the Sheraton San Diego Hotel and Marina ... Attendees will have the opportunity to speak with company ... Development: Paths That Cross" on May 21 from 1-2 ...
(Date:5/20/2013)... HILL, N.C. , May 20, 2013 /PRNewswire/ ... company focused on developing differentiated antibiotics to meet ... infections, today announced that it presented data at ... in Philadelphia demonstrating the ... levofloxacin in Cempra,s prior Phase 2 clinical trial ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
Cached News: